NIH-funded research R01 grant

Understanding how radiation therapy affects thinking skills in glioma patients

Official title: Mechanisms of Radiation-Induced Neurocognitive Decline (MIND): Longitudinal Study of Imaging Biomarkers and Risk and Resilience Factors Underlying Cognitive Phenotypes in Patients with Glioma

Funded at University of California, San Diego · NIH-11047478 · Data updated 2026-11-12

This study is looking at how radiation therapy affects thinking and memory in people with glioma, and it aims to find ways to help protect brain function during treatment.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startDecember 5, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$667,485
NIH project number1R01CA289833-01A1
Project IDNIH-11047478 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are glioma patients who are undergoing radiation therapy and are 21 years or older.

Less likely to help

Patients with glioma who are not receiving radiation therapy may not benefit from this research.

What this research studies

This research investigates the cognitive decline that often occurs in glioma patients following radiation therapy. By using advanced imaging techniques and a patient-centered approach, the study aims to identify different cognitive profiles and the underlying mechanisms of this decline. It will also explore various risk and resilience factors that may influence cognitive outcomes. Patients will be monitored over time to better understand how radiation impacts brain function and to develop strategies for minimizing cognitive damage.

Why it matters

Potential benefit: If successful, this research could lead to improved radiation therapy techniques that preserve cognitive function in glioma patients.

How similar studies have gone: Previous research has shown promising results in understanding cognitive decline related to cancer treatments, but this study aims to explore new methodologies and insights.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Hattangadi-Gluth, Jona a — University of California, San Diego
  • Study coordinator: Hattangadi-Gluth, Jona a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.